Figure 1
The model and protocol. (A) Schematic of the multistep process of leukemogenesis and derivation of the animal models of NRASD12 and hBCL-2–mediated MDS and AML. (B) ABT-737 treatment protocol. MA, membrane anchor.
The model and protocol. (A) Schematic of the multistep process of leukemogenesis and derivation of the animal models of NRASD12 and hBCL-2–mediated MDS and AML. (B) ABT-737 treatment protocol. MA, membrane anchor.
